Loading...
research article
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5
To report vision and safety outcomes from an extension of a 2-year investigation evaluating verteporfin photodynamic therapy in patients with age-related macular degeneration with subfoveal choroidal neovascularization (CNV).
Type
research article
Authors
Blumenkranz, Mark S.
•
Bressler, Neil M.
•
Bressler, Susan B.
•
Donati, Guy
•
Fish, Gary Edd
•
Haynes, Laurie A.
•
Lewis, Hilel
•
Miller, Joan W.
•
Monés, Jordi M.
•
Potter, Michael J.
Publication date
2002
Publisher
Published in
Volume
120
Issue
10
Start page
1307
End page
1314
Subjects
Note
Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group
Peer reviewed
REVIEWED
Available on Infoscience
February 1, 2011
Use this identifier to reference this record